Show
Sort by
-
Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapy
-
Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate
-
Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA
-
Comparison of the ACR and ESUR PIRADSv1 and v2 in a cohort of 245 patients with histopathological and/or long term follow up
-
What kind of prostate cancers do we miss on multiparametric magnetic resonance imaging?